MSTP at Mayo Clinic Rochester
MSTP at Mayo Clinic Rochester
批准号:
10409857
负责人:
SCOTT H KAUFMANN
金额:
$116.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The mission of the Mayo Clinic Medical Scientist Training Program (MSTP) is to train clinician-scientist leaders
of the future. Our program is designed to mentor a diverse group of trainees whom we individually guide on
their journeys to develop the technical, operational, and professional skills to support a productive career in
which they integrate research and clinical activities to advance biomedical science. In order to fulfill our mission
of developing these future clinician-scientist leaders, we propose four measurable objectives that will serve as
the foundation of our program: 1) To provide a fully integrated scientific and clinical training program that will
help trainees develop the skills needed to recognize and address important clinical problems while
simultaneously enabling our graduates to move easily between research and clinical environments; 2) To
develop a diverse group of future leaders who possess the self-confidence and communication skills to share
scientific concepts with colleagues and individuals at all scientific levels as well as scientific and political leaders;
3) To encourage trainees to develop self-reflective skills that will lead to rigor in their own science and recognition
of instances where rigor and reproducibility tenets may be lacking; and 4) To provide trainees with experiences
that reflect their own long-term scientific goals in academia or other careers. This MSTP admits nine MD-PhD
trainees per year from a pool of over three hundred applicants. Ninety-six carefully vetted and trained laboratory
mentors will provide a safe learning environment and guide rigorous research. The co-Directors, Drs. Schimmenti
and Kaufmann, have over thirty years of combined experience in MD-PhD leadership and are committed to the
success and well-being of every trainee. Under-represented trainees make up seventeen percent of the trainee
cohort, with planned enrollment of twenty percent at the end of the 2021 admissions season. Mayo Clinic’s three-
part mission comprised of patient care, research, and education, provides a rich environment for training. The
average time to degree for the last ten years of graduates is 8.18 years, with a mean of 4.3 first author papers
per trainee and 8.7 total papers per trainee. Trainees are required to submit an F award or equivalent; and the
success rate over the last ten years has been 58%. Trainees match well, with three of five trainees matching in
physician scientist training programs in 2021. A self-reflective iterative evaluation process has been developed
and implemented to support cycles of program improvement with goals to support rigor and reproducibility
training, trainee retention, a diverse learning community, decreased time to degree, scholarship, and career
satisfaction. The long-term goal of the program is to provide each dual-degree graduate a firm foundation for a
lifetime of career success in research and research related fields.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Biventricular catheterization combined with pressure-volume loop monitoring provides insight into the dynamic effects of left ventricular assist devices ramp on right ventricular function.
双心室导管插入术与压力-容量环路监测相结合,可以深入了解左心室辅助装置斜坡对右心室功能的动态影响。
DOI:
10.1002/ccd.30993
发表时间:
2024
期刊:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
影响因子:
--
作者:
[Garmany,Armin, Inglis,SaraS, Behfar,Atta, Rosenbaum,AndrewN]
通讯作者:
Rosenbaum,AndrewN
DOI:
10.1038/s41598-023-40795-1
发表时间:
2023-09-01
期刊:
Scientific reports
影响因子:
4.6
作者:
[]
通讯作者:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
-
批准号:10438886
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
-
批准号:10296087
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2021
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
-
批准号:10656207
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:SCOTT H KAUFMANN
-
依托单位:
BAK Autoactivation in Hematological Malignancies
-
批准号:10425322
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:SCOTT H KAUFMANN
-
依托单位:
BAK Autoactivation in Hematological Malignancies
-
批准号:10188459
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2020
-
负责人:SCOTT H KAUFMANN
-
依托单位:
BAK Autoactivation in Hematological Malignancies
-
批准号:10684892
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Deubiquitinases in regulation of BRCA1 pathway
-
批准号:10006119
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2016
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Regulation of Death Ligand-Induced Killing
-
批准号:8884794
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2015
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
-
批准号:9020939
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2015
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8273913
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8640764
-
项目类别:
-
资助金额:$31.18万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8828123
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:8459985
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Anticancer drug-induced BH3-only protein.Bak interactions
-
批准号:9056441
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2012
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Project 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian Cancer
-
批准号:10452720
-
项目类别:
-
资助金额:$26.16万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Project 1 - PARP Project
-
批准号:8932128
-
项目类别:
-
资助金额:$17.31万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Administration Core
-
批准号:10705035
-
项目类别:
-
资助金额:$12.96万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Administration Core
-
批准号:10268759
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Mayo Clinic Ovarian Cancer SPORE
-
批准号:10452715
-
项目类别:
-
资助金额:$174.98万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
Project 1 - PARP Project
-
批准号:9333234
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2009
-
负责人:SCOTT H KAUFMANN
-
依托单位:
海外基金